Navigation Links
Excess protein linked to development of Parkinson's disease
Date:2/7/2013

Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells' center, with the potential consequence of progressive degeneration and eventual cell death.

The findings, published in the February 6, 2013 issue of the Journal of Neuroscience, have major implications for more fully understanding the causes and mechanisms of Parkinson's disease (PD), a neurodegenerative movement disorder that affects an estimated one million Americans.

"This is an important new insight. I don't think anybody realized just how big a role alpha-synuclein played in managing the retrieval of worn-out proteins from synapses and the role of alterations in this process in development of PD," said principal investigator Mark H. Ellisman, PhD, professor of neurosciences and bioengineering and director of the National Center for Microscopy and Imaging Research (NCMIR), based at UC San Diego.

Parkinson's disease is characterized by the gradual destruction of select brain cells that produce dopamine, a neurotransmitter involved in regulating movement and emotion. Symptoms include increasing loss of muscle and movement control. While most cases are sporadic that is, their causes are unknown there are also inherited forms of PD linked to specific gene mutations and modifications.

The UC San Diego researchers, with colleagues at the University of Illinois, Urbana, focused upon one of those gene products: alpha-synuclein. Using a variety of leading-edge imaging technologies, including a new fluorescent tagging technique developed for electron microscopy by UC San Diego Nobel laureate Roger Tsien's lab and colleagues at NCMIR, the scientists created three-dimensional maps of alpha-synuclein distribution both in cultured neurons and in the ne
'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Excessive alcohol use when youre young could have lasting impacts on your brain
2. Neuroscientists find excessive protein synthesis linked to autistic-like behaviors
3. Can Excessive Cellphone Use Become an Addiction?
4. Excess Pounds Raise Risk of Breast Cancer Recurrence, Death: Study
5. College Freshmen Urged to Keep Excess Pounds Away
6. Simple Measures May Curb Excessive Weight Gain in Pregnancy
7. Excessive sleepiness may be cause of learning, attention and school problems
8. Muscular Development Store Comments on Efficacy of Protein Blends
9. Scientists discover protein that allows safe recycling of iron from old red blood cells
10. The Muscular Development Store Comments on How Optimum Nutrition’s Protein Supplements Fit Into Your Workout
11. DNA-repairing protein may be key to preventing recurrence of some cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Excess protein linked to development of Parkinson's disease
(Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Payday lending ... vulnerable communities and cause financial distress to the states ... analysts at Howard University’s Center on Race and Wealth. ... in economic activity, payday loans at the same time ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... Just in Case, Inc., the makers of,the first high ... their compacts to women,s Non-Profit Groups Nationwide. They are,CALLING ... will be,chosen to receive 100 JUST IN CASE(R) compacts ... The 10,000 compact give-away will help raise awareness ...
... RATON, Fla., Jan. 11 Breckenridge,Pharmaceutical, Inc. ... with Novartis concerning Trileptal(R) and that the ... New Drug,Application for oxcarbazepine 150mg, 300mg and ... Tablets")., Breckenridge enjoys a shared 180-day ...
... HILL People given a biological and genetics-based explanation ... to blame people with anorexia for their illness than ... Carolina at Chapel Hill study found. , This is ... Crisafulli, because it suggests that wider dissemination of information ...
... Jan. 11 Life Brokerage Partners,announces three ... Group and Nationwide. With these new additions, ... products at some of the most,exclusive national ... a,national insurance brokerage agency., New relationships ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ) today ... four pivotal, Phase III clinical trials of Acetavance(TM), ... these clinical,trials did not meet its primary endpoint ... intensity levels over 48 hours,compared to placebo, following ...
... NEW YORK, Jan. 10 MultiVu, PR Newswire,s ... promotion of,George DeTorres to the position of divisional ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080110/NYTH078 ) ... http://www.newscom.com/cgi-bin/prnh/20020501/NYW077LOGO ...
Cached Medicine News:Health News:Teen Pregnancy Epidemic Another Reason for Women to Carry Condoms. Just in Case, Inc. Announces 10,000 Chic Condom Compact Give-Away to Women's Non-Profits Nationwide. 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 3Health News:Life Brokerage Partners Adds New Insurance Carriers 2Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 2Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 3Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 4Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 5Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 6Health News:Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) 7Health News:Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team 2Health News:Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team 3
(Date:1/22/2015)... Inc. (NYSE: RMD ) today announced results for ... was $423.0 million, a 10 percent increase compared to the ... a constant currency basis). Net income was $91.2 million, an ... 31, 2013. Diluted earnings per share for the quarter were ...
(Date:1/22/2015)... Jan. 22, 2015  Profil Institute for Clinical Research, Inc., ... obesity, announced today a new textbook,  Translational Research Methods ... Springer, a leading global scientific publisher. The ... techniques for use in early phase clinical studies of ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has ... Allergen Source, Product & by End User - Global Forecast ... The global allergy diagnostics market is valued at $1,228.58 million ... of 12.67%, to reach $2,230.72 million by 2019. Allergy diagnostics ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... 16, 2011 Chimerix, Inc., a biotechnology company ... will present preliminary data for CMX001 in a ... on Antimicrobial Agents and Chemotherapy (ICAAC, Chicago – ... Associate Member of Infectious Diseases Service at Memorial ...
... Pathfinder Cell Therapy, Inc. ("Pathfinder")(OTCQB: PFND), a biotechnology company ... cell damage, today announced that effective at the start ... stock will change from SYMD to PFND.  The new ... name and has been approved by the Financial Industry ...
Cached Medicine Technology:Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3Pathfinder Cell Therapy, Inc. Announces New Stock Ticker Symbol 2
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With cast ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... lumbar support • Select options ... casters and glides. • BTT/1P ... following environments: industry, education, laboratory, ...
Medicine Products: